Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 1 23-1, 2000, Pages

  Lee, Young M ^a   Hybertson, Brooks M ^a   Cho, Hyun G ^b   Terada, Lance S ^a   Cho, Okyong ^a   Repine, Alexander J ^a   Repine, John E ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b Catholic University of Daegu   (South Korea)

^c Box C321 ^*  (United States)

Author keywords

Acute lung injury; Neutrophils

Indexed keywords

ACYLTRANSFERASE; APAFANT; INTERLEUKIN 1; MYELOPEROXIDASE; NITROBLUE TETRAZOLIUM; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG EDEMA; LUNG ENDOTHELIUM; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033865680     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.1.l75     Document Type: Article

References (42)

1. 2 regulates critical inflammatory mediators of multiple organ failure. J Surg Res 56: 199-205, 1994.
2. Braquet P, Touqui L, Shen TY, and Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 39: 97-145, 1987.
3. Bratt J and Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol 159: 912-918, 1997.
4. Breviario F, Bertocchi F, Dejana E, and Bussolino F. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. J Immunol 141: 3391-3397, 1988.
5. Briggs RT, Drath DB, Karnovsky ML, and Karnovsky MJ. Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J Cell Biol 67: 566-586, 1975.
6. Casals-Stenzel J and Heuer HO. Use of WEB-2086 and WEB 2170 as platelet-activating factor antagonists. Methods Enzymol 187: 455-465, 1990.
7. Goldblum SE, Wu KM, and Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 59: 1978-1985, 1985.
8. Hobson J, Wright J, and Churg A. Histochemical evidence for generation of active oxygen species on the apical surface of cigarette-smoke-exposed tracheal explants. Am J Pathol 139: 573-580, 1991.
9. Hybertson BM, Lee YM, Jepson EK, Cho OJ, Clarke JH, and Repine JE. Tumor necrosis factor activity is necessary for lung leak, but not neutrophil accumulation, in rats given IL-1 intratracheally. Am J Respir Crit Care Med 155: 1972-1976, 1997.
10. Hybertson BM, Leff JA, Beehler CJ, Barry PC, and Repine JE. Effect of vitamin E deficiency and supercritical fluid aerosolized vitamin E supplementation on interleukin-1-induced oxidative lung injury in rats. Free Radic Biol Med 18: 537-542, 1995.
11. Ingraham L, Coates T, Allen J, Higgins C, Baehner R, and Boxer L. Metabolic membrane and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood 59: 1259-1266, 1982.
12. Karnovsky MJ. Robert Feulgen Lecture 1994. Cytochemistry and reactive oxygen species: a retrospective. Histochemistry 102: 15-27, 1994.
13. 2 activities are increased in human adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 269: L109-L118, 1995.
14. Kim FJ, Moore EE, Moore FA, Biffl WL, Fontes B, and Banerjee A. Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res 58: 636-640, 1995.
15. Koh Y, Hybertson BM, Jepson EK, Cho OJ, and Repine JE. Cytokine-induced neutrophil chemoattractant is necessary for interleukin-1-induced lung leak in rats. J Appl Physiol 79: 472-478, 1995.
16. Kubes P, Ibbotson G, Russell J, Wallace JL, and Granger DN. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol Gastrointest Liver Physiol 259: G300-G305, 1990.
17. Kuijpers TW, Hakkert BC, Hart MH, and Roos D. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol 117: 565-572, 1992.
18. Lee YM, Hybertson BM, Terada LS, Repine AJ, Cho HG, and Repine JE. Mepacrine decreases lung leak in rats given interleukin-1 intratracheally. Am J Respir Crit Care Med 155: 1624-1628, 1997.
19. Leff JA, Baer JW, Bodman ME, Kirkman JM, Shanley PF, Patton LM, Beehler CJ, McCord JM, and Repine JE. Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats. Am J Physiol Lung Cell Mol Physiol 266: L2-L8, 1994.
20. Leff JA, Wilke CP, Hybertson BM, Shanley PF, Beehler CJ, and Repine JE. Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats. Am J Physiol Lung Cell Mol Physiol 265: L501-L506, 1993.
21. Lien DC, Worthen GS, Henson PM, and Bethel RA. Platelet-activating factor causes neutrophil accumulation and neutrophil-mediated increased vascular permeability in canine trachea. Am Rev Respir Dis 145: 693-700, 1992.
22. Luce JM. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 26: 369-376, 1998.
23. Lynch JM, Lotner GZ, Betz SJ, and Henson PM. The release of a platelet-activating factor by stimulated rabbit neutrophils. J lmmunol 123: 1219-1226, 1979.
24. Matsumoto K, Taki F, Kondoh Y, Taniguchi H, and Takagi K. Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin Exp Pharmacol Physiol 19: 509-515, 1992.
25. Nakos G, Kitsiouli EI, Tsangaris I, and Lekka ME. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med 24: 296-303, 1998.
26. Pittet JF, Mackersie RC, Martin TR, and Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155: 1187-1205, 1997.
27. Prasad K, Kapoor R, and Lee P. Purpurogallin, a scavenger of polymorphonuclear leukocyte-derived oxyradicals. Mol Cell Biochem 139: 27-32, 1994.
28. Pugin J, Ricou B, Steinberg KP, Suter PM, and Martin TR. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 153: 1850-1856, 1996.
29. Repine JE. Interleukin-1-mediated acute lung injury and tolerance to oxidative injury. Environ Health Perspect 102: 75-78, 1994.
30. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 339: 466-469, 1992.
31. Ribaldi E, Mezzasoma AM, Francescangeli E, Prosdocimi M, Nenci GG, Goracci G, and Gresele P. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation. Br J Pharmacol 118: 1351-1358, 1996.
32. Rubin RM and Rosenbaum JT. A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. Biochem Biophys Res Commun 154: 429-435, 1988.
33. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta 1254: 231-249, 1995.
34. Sorensen J, Kald B, Tagesson C, and Lindahl M. Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma. Intensive Care Med 20: 555-561, 1994.
35. Summers JB and Albert DH. Platelet activating factor antagonists. Adv Pharmacol 32: 67-168, 1995.
36. Tamaoki J, Yamawaki I, Tagaya E, Kondo M, Aoshiba K, Nakata J, and Nagai A. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. Am J Physiol Lung Cell Mol Physiol 276: L351-L357, 1999.
37. Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, and Repine JE. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 89: 3362-3366, 1992.
38. Vercellotti GM, Yin HQ, Gustafson KS, Nelson RD, and Jacob HS. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 71: 1100-1109, 1988.
39. Warren JS. Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. Am J Pathol 141: 551-560, 1992.
40. Warren JS, Kunkel RG, Simon RH, Johnson KJ, and Ward PA. Ultrastructural cytochemical analysis of oxygen radical-mediated immunoglobulin A immune complex induced lung injury in the rat. Lab Invest 60: 651-658, 1989.
41. Worthen GS, Goins A, Mitchell B, Larsen G, Reeves J, and Henson PM. Effects of intravascular C5 fragments and platelet activating factor on lung injury and neutrophil accumulation in the rabbit (Abstract). Am Rev Respir Dis 125: 274, 1982.
42. Yamazaki R, Sugatani J, Fujii I, Kuroyanagi M, Umehara K, Ueno A, Suzuki Y, and Miwa M. Development of a novel method for determination of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex. Biochem Pharmacol 47: 995-1006, 1994.